Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02859337 · ClinicalTrials.gov registry record · Phase 4
Effectiveness of Orally Dosed Emergency Contraception in Obese Women - UPA
A Phase 4 study, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- Phase 4
- Development phase
- 64
- Enrollment target
NCT02859337 is a Phase 4 study that has completed, run by Oregon Health and Science University. The registered enrollment target is 64 participants.
The verdict
NCT02859337, a Phase 4 study, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 64 participants
- Enrollment target
Study Summary
Obese women are significantly more likely than their normal BMI counterparts to experience failure of orally-dosed emergency contraceptives. Our preliminary data provides evidence for testing a dose escalation strategy in an effort to provide improved efficacy from orally-dosed emergency contraceptives in obese women. More data is needed regarding emergency contraception containing ulipristal acetate. The overall project will be focused on both levonorgestrel (LNG) - and ulipristal acetate (UPA)-containing emergency contraception but this protocol registration is for the UPA aspect of the study procedures.
Interventions
- DRUG UPA-ECx1
- DRUG UPA-ECx2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2017-05-30 |
| Est. Completion | 2023-11-15 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02859337
The ClinicalTrials.gov registry entry for NCT02859337 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which UPA-ECx1 is the first listed.
NCT02859337 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02859337 about?
NCT02859337 is a clinical study titled "Effectiveness of Orally Dosed Emergency Contraception in Obese Women - UPA". Obese women are significantly more likely than their normal BMI counterparts to experience failure of orally-dosed emergency contraceptives. Our preliminary data provides evidence for testing a dose escalation strategy in an effort to provide improved efficacy from orally-dosed emergency contracepti...
What is the current status of trial NCT02859337?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 64 participants. The study started on 2017-05-30. Estimated completion is 2023-11-15.
What interventions are being tested in trial NCT02859337?
The interventions under investigation include: UPA-ECx1 (DRUG), UPA-ECx2 (DRUG).
Who is sponsoring clinical trial NCT02859337?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.